Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway

Proteasomal degradation of topoisomerase I (topoI) is one of the most remarkable cellular phenomena observed in response to camptothecin (CPT). Importantly, the rate of topoI degradation is linked to CPT resistance. Formation of the topoI-DNA-CPT cleavable complex inhibits DNA re-ligation resulting...

Full description

Bibliographic Details
Main Authors: Ando, Koji, Shah, Ankur K., Sachdev, Vibhu, Kleinstiver, Benjamin P., Taylor-Parker, Julian, Welch, Moira M., Hu, Yiheng, Salgia, Ravi, Parvin, Jeffrey D., Ozonoff, Al, Rameh, Lucia E., Joung, J. Keith, Bharti, Ajit K., White, Forest M.
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:en_US
Published: Impact Journals/National Center for Biotechnology Information (U.S.) 2017
Online Access:http://hdl.handle.net/1721.1/109949
https://orcid.org/0000-0002-1545-1651
_version_ 1811097710932000768
author Ando, Koji
Shah, Ankur K.
Sachdev, Vibhu
Kleinstiver, Benjamin P.
Taylor-Parker, Julian
Welch, Moira M.
Hu, Yiheng
Salgia, Ravi
Parvin, Jeffrey D.
Ozonoff, Al
Rameh, Lucia E.
Joung, J. Keith
Bharti, Ajit K.
White, Forest M.
author2 Massachusetts Institute of Technology. Department of Biological Engineering
author_facet Massachusetts Institute of Technology. Department of Biological Engineering
Ando, Koji
Shah, Ankur K.
Sachdev, Vibhu
Kleinstiver, Benjamin P.
Taylor-Parker, Julian
Welch, Moira M.
Hu, Yiheng
Salgia, Ravi
Parvin, Jeffrey D.
Ozonoff, Al
Rameh, Lucia E.
Joung, J. Keith
Bharti, Ajit K.
White, Forest M.
author_sort Ando, Koji
collection MIT
description Proteasomal degradation of topoisomerase I (topoI) is one of the most remarkable cellular phenomena observed in response to camptothecin (CPT). Importantly, the rate of topoI degradation is linked to CPT resistance. Formation of the topoI-DNA-CPT cleavable complex inhibits DNA re-ligation resulting in DNA-double strand break (DSB). The degradation of topoI marks the first step in the ubiquitin proteasome pathway (UPP) dependent DNA damage response (DDR). Here, we show that the Ku70/Ku80 heterodimer binds with topoI, and that the DNA-dependent protein kinase (DNA-PKcs) phosphorylates topoI on serine 10 (topoI-pS10), which is subsequently ubiquitinated by BRCA1. A higher basal level of topoI-pS10 ensures rapid topoI degradation leading to CPT resistance. Importantly, PTEN regulates DNA-PKcs kinase activity in this pathway and PTEN deletion ensures DNA-PKcs dependent higher topoI-pS10, rapid topoI degradation and CPT resistance.
first_indexed 2024-09-23T17:03:41Z
format Article
id mit-1721.1/109949
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T17:03:41Z
publishDate 2017
publisher Impact Journals/National Center for Biotechnology Information (U.S.)
record_format dspace
spelling mit-1721.1/1099492022-10-03T10:08:08Z Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway Ando, Koji Shah, Ankur K. Sachdev, Vibhu Kleinstiver, Benjamin P. Taylor-Parker, Julian Welch, Moira M. Hu, Yiheng Salgia, Ravi Parvin, Jeffrey D. Ozonoff, Al Rameh, Lucia E. Joung, J. Keith Bharti, Ajit K. White, Forest M. Massachusetts Institute of Technology. Department of Biological Engineering Koch Institute for Integrative Cancer Research at MIT White, Forest M Proteasomal degradation of topoisomerase I (topoI) is one of the most remarkable cellular phenomena observed in response to camptothecin (CPT). Importantly, the rate of topoI degradation is linked to CPT resistance. Formation of the topoI-DNA-CPT cleavable complex inhibits DNA re-ligation resulting in DNA-double strand break (DSB). The degradation of topoI marks the first step in the ubiquitin proteasome pathway (UPP) dependent DNA damage response (DDR). Here, we show that the Ku70/Ku80 heterodimer binds with topoI, and that the DNA-dependent protein kinase (DNA-PKcs) phosphorylates topoI on serine 10 (topoI-pS10), which is subsequently ubiquitinated by BRCA1. A higher basal level of topoI-pS10 ensures rapid topoI degradation leading to CPT resistance. Importantly, PTEN regulates DNA-PKcs kinase activity in this pathway and PTEN deletion ensures DNA-PKcs dependent higher topoI-pS10, rapid topoI degradation and CPT resistance. 2017-06-16T15:15:36Z 2017-06-16T15:15:36Z 2017-03 2017-02 Article http://purl.org/eprint/type/JournalArticle 1949-2553 http://hdl.handle.net/1721.1/109949 Ando, Koji; Shah, Ankur K.; Sachdev, Vibhu; Kleinstiver, Benjamin P.; Taylor-Parker, Julian; Welch, Moira M.; Hu, Yiheng et al. “Camptothecin Resistance Is Determined by the Regulation of Topoisomerase I Degradation Mediated by Ubiquitin Proteasome Pathway.” Oncotarget (November 2015): 16376 https://orcid.org/0000-0002-1545-1651 en_US http://dx.doi.org/10.18632/oncotarget.16376 Oncotarget Creative Commons Attribution 3.0 Unported license http://creativecommons.org/licenses/by/3.0/ application/pdf Impact Journals/National Center for Biotechnology Information (U.S.) Impact Journals
spellingShingle Ando, Koji
Shah, Ankur K.
Sachdev, Vibhu
Kleinstiver, Benjamin P.
Taylor-Parker, Julian
Welch, Moira M.
Hu, Yiheng
Salgia, Ravi
Parvin, Jeffrey D.
Ozonoff, Al
Rameh, Lucia E.
Joung, J. Keith
Bharti, Ajit K.
White, Forest M.
Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway
title Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway
title_full Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway
title_fullStr Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway
title_full_unstemmed Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway
title_short Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway
title_sort camptothecin resistance is determined by the regulation of topoisomerase i degradation mediated by ubiquitin proteasome pathway
url http://hdl.handle.net/1721.1/109949
https://orcid.org/0000-0002-1545-1651
work_keys_str_mv AT andokoji camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway
AT shahankurk camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway
AT sachdevvibhu camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway
AT kleinstiverbenjaminp camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway
AT taylorparkerjulian camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway
AT welchmoiram camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway
AT huyiheng camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway
AT salgiaravi camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway
AT parvinjeffreyd camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway
AT ozonoffal camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway
AT ramehluciae camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway
AT joungjkeith camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway
AT bhartiajitk camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway
AT whiteforestm camptothecinresistanceisdeterminedbytheregulationoftopoisomeraseidegradationmediatedbyubiquitinproteasomepathway